YOSHIO YAMAOKA to Duodenal Ulcer
This is a "connection" page, showing publications YOSHIO YAMAOKA has written about Duodenal Ulcer.
Connection Strength
5.453
-
Comparative genomics of two Vietnamese Helicobacter pylori strains, CHC155 from a non-cardia gastric cancer patient and VN1291 from a duodenal ulcer patient. Sci Rep. 2023 05 31; 13(1):8869.
Score: 0.778
-
Genome-wide association study of gastric cancer- and duodenal ulcer-derived Helicobacter pylori strains reveals discriminatory genetic variations and novel oncoprotein candidates. Microb Genom. 2021 11; 7(11).
Score: 0.697
-
Helicobacter pylori therapy and clinical perspective. J Glob Antimicrob Resist. 2018 09; 14:111-117.
Score: 0.543
-
Helicobacter pylori cagA 12-bp insertion can be a marker for duodenal ulcer in Okinawa, Japan. J Gastroenterol Hepatol. 2013 Feb; 28(2):291-6.
Score: 0.380
-
The intact dupA cluster is a more reliable Helicobacter pylori virulence marker than dupA alone. Infect Immun. 2012 Jan; 80(1):381-7.
Score: 0.348
-
Prevalence of two homologous genes encoding glycosyltransferases of Helicobacter pylori in the United States and Japan. J Gastroenterol Hepatol. 2011 Sep; 26(9):1451-6.
Score: 0.344
-
Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol. 2010 Nov; 7(11):629-41.
Score: 0.324
-
homB status of Helicobacter pylori as a novel marker to distinguish gastric cancer from duodenal ulcer. J Clin Microbiol. 2009 Oct; 47(10):3241-5.
Score: 0.300
-
Proteomic Helicobacter pylori biomarkers discriminating between duodenal ulcer and gastric cancer. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Apr 15; 877(11-12):1193-9.
Score: 0.290
-
Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology. 2005 Apr; 128(4):833-48.
Score: 0.221
-
Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island. Am J Gastroenterol. 2002 Sep; 97(9):2231-8.
Score: 0.185
-
Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise. Helicobacter. 2000; 5 Suppl 1:S3-9; discussion S27-31.
Score: 0.153
-
Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status. Gut. 1999 Dec; 45(6):804-11.
Score: 0.153
-
Prevalence of Helicobacter pylori and its CagA subtypes in gastric cancer and duodenal ulcer at an Austrian tertiary referral center over 25 years. PLoS One. 2018; 13(5):e0197695.
Score: 0.137
-
Helicobacter pylori from gastric cancer and duodenal ulcer show same phylogeographic origin in the Andean region in Colombia. PLoS One. 2014; 9(8):e105392.
Score: 0.106
-
Helicobacter pylori iceA, clinical outcomes, and correlation with cagA: a meta-analysis. PLoS One. 2012; 7(1):e30354.
Score: 0.088
-
Levels of interleukin-18 are markedly increased in Helicobacter pylori-infected gastric mucosa among patients with specific IL18 genotypes. J Infect Dis. 2008 Jun 15; 197(12):1752-61.
Score: 0.069
-
One- or two-week triple therapy for Helicobacter pylori: questions of efficacy and inclusion of a dual therapy treatment arm. Gut. 2007 Jul; 56(7):1021-3; author reply 1022-3.
Score: 0.065
-
Helicobacter pylori environmental interactions: effect of acidic conditions on H. pylori-induced gastric mucosal interleukin-8 production. Cell Microbiol. 2007 Oct; 9(10):2457-69.
Score: 0.064
-
Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome. Clin Gastroenterol Hepatol. 2007 Jan; 5(1):49-58.
Score: 0.062
-
Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut. 2006 Jun; 55(6):775-81.
Score: 0.058
-
The interleukin-1 RN polymorphism and Helicobacter pylori infection in the development of duodenal ulcer. Helicobacter. 2004 Dec; 9(6):605-13.
Score: 0.054
-
H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter. 1998 Sep; 3(3):145-51.
Score: 0.035